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THE experiments described in this paper were intended to test whether the
hypothyroidism provoked by prolonged administration ofgoitrogenic substances
such as thiourea affected the development of spontaneous mammary tumours in
mice ofhigh cancer strains in a way comparable to that of restricted diets. No
definite conclusions were obtained with regard to the influence of the thyroid
gland, but the results showed a remarkable reduction of mammary cancer in
one of the two strains used. Preliminary experiments (Vazquez-Lopez, 1946;
Morris, Dubnik and Dalton, 1946a, b) showed that thiourea ingestion produced a
continuous anoestrus due to ovarian atrophy and the consequent underdevelop-
ment of the mammary glands. The effect ofthiourea was therefore more or less
the equivalent of ovariectomy. Inasmuch as this effect depended on continuous
ingestion it was decided to withdraw the drug after a certain period, thus restoring
ovarian function and allowing the mammary glands to reach a stage of develop-
ment comparable to that ofthe control animals before the average time oftumour
appearance. In that case the effects observed could not be attributed to the
underdeveloped condition of the gland, but could be due only to the lack of
oestrogenic activity during a limited period of the life of the mice.
MATERIAL AND METHODS
C3H and R3 female mice bred in this laboratory by brother-sister mating for
several years were used. The R3 mice belong to two different lines, only one
ofwhich had the high incidence of mammary cancer characteristic of this strain.
The other line originated some time ago in this laboratory after mating two
animals from different litters with the intention of improving breeding perfor-
mance. After some generations it was found that the progeny of this pair
had lost the characteristic high incidence of mammary cancer and become a
low cancer line. Simultaneously with the loss of mammary cancer incidence
this line developed a high incidence of lymphomas in breeding females, and thus
provided the opportunity of testing the effect ofthiourea in another kind ofspon-
taneous tumour. The animals of this line (MH) used in the present experiment
belonged to the 5th to 8th generations after the original cross, and most of
them were born between June and September, 1946. Continuous brother-sister
mating of the animals selected as descendants of the females with the earliest
leukaemia development maintained the same incidence of lymphoma and
mammary cancer till the 16th generation.4E. VAZQUEZ-LOPEZ
Breeding females only were used from the two lines of R3 mice, and both
breeders and virgins from the C3H strain. The breeders were allowed to rear
their first litters and, after weaning, the mothers were taken for the experiment.
The litters of the C3H breeders provided the majority of the virgins employed.
In all groups care was taken to divide animals of the same litters between the
experimental and control groups.
The animals were housed in metal boxes, 6 to 8 in each, and fed rat cubes
and water'ad lib. Breeders and virgins of the C3H strain were separated, but
the two lines of R3 breeders were mixed together.
Thiourea was administered in the drinking water, beginning with a 0 1 percent
solution andincreasing the concentration as much as possible without endangering
the survival of the animals. The approximate amount of fluid ingested was
determined by dividing the total content of the water bottles by the number of
animals in the box. All the animals were individually marked. The age of the
breeders at the beginning of thiourea ingestion was between 3 and 4 months.
The virgins were 3 months old, so that the mammary gland was fully developed
before the action of the drug started.
The period of administration for some of the R3 animals was a year, so that
most of the animals with tumours died during the period of ingestion. For the
C3H mice, both breeders and virgins, it was 6 months, so that the animals were
under normal conditions again when 9 or 10 months old. They were weighed
regularly and inspected daily for the appearance of tumours. Vaginal smears
were taken several times both during the period of thiourea ingestion and after-
wards. In the virgins the presence of oestrus was also established before the
start of the experiment to make sure that they had reached sexual maturity.
The animals were allowed to live their full life span; only those in moribund
condition were killed.
The tumours, aswell as ovaries, uterus andadrenalglands ofmice inthe control
and experimental groups were fixed for histological study. The' thyroid was also
examined and whole mounts of the mammary glands prepared in the usual way.
The most detailed study was made in the C3H virgins of both experimental and
control groups.
Effects of ThIiourea.
General effects.
There were very pronounced differences between the effects of thiourea in
the two strains R3 and C3H. In both lines of R3 mice, those with high and low
cancer incidence, the ingestion of the 0.1 per cent solution had no effect on the
appearance, weight or water intake ofthe animals, and the strengthofthesolution
could be increased to 0.5 per cent and maintained for long periods. Even con-
centrations of 1 per cent could be used before the mice showed toxic signs such as
loss ofweight and reduction ofwater intake. Ifthe solutions were kept between
0-2 per cent and 0*5 per cent the R3 mice could be maintained for most of their
lives without any apparent difference from the controls. The average length of
the experiment was 10 months.
The C3H mice, both virgins and breeders, appeared on the contrary extremely
susceptible to thiourea. Some animals died during the first days ofingestion,
and even with a 0-1 per cent concentration they showed marked intolerance,
mainly by loss of weight, restriction of fluid intake and poor appearance. The
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average weight of the animals during thiourea ingestion was 18 g. for the virgins
and 21 g. for the breeders, compared with 24 and 28 g. for the control groups.
The water intake was progressively reduced to a minimum of about 2 ml. per
animal per day, and if the concentration of the drug was not reduced, many
animals died. It was possible to reach a concentration of 0 5 per cent in most
boxes, but it could be maintained only for one or two weeks. Solutions of 0-2
and 0.1 per cent were used most of the time, and even with these doses the
intolerance to the drug and mounting mortality necessitated the withdrawal ofthe
drug after 4 or 5 months. After some days without thiourea the mice recovered
and the drug could then be administered again, but the recurrence of toxic
symptoms was rapid. It was preferable to maintain the 6months' periodwithout
interruption, even at the risk of losing more animals in the last months of treat-
ment.
The doses administered were therefore variable for the different animals
and for different periods for the same animal, but from the approximate estimate
of water intake it may be assumed that the minimum of thiourea ingested per
day was between 2 and 3 mg. for the C3H mice. For most R3 strain mice it was
maintained at a level ofabout 15 mg. per day during most ofthe experiment, and
during some periods it reached 30 mg. daily.
Effects on the thyroid gland.
In the R3 mice the ingestion of thiourea provoked the typical hypertrophy
and hyperplasia with great vascularity, loss of colloid, etc. This effect was
evident even with a 0-2 per cent solution, and became more pronounced in pro-
portion to the length of treatment and increased concentration. As the majority
of the animals with tumours died during the period of thiourea ingestion, the
maximum effect was observed directly. The mice surviving after the withdrawal
of the drug had thyroids of normal size and structure without any signs of the
former hyperplasia.
The effects ofthiourea in C3H mice were observed in the experimental animals
that died during the period of ingestion of the drug. As the great majority of
these mice restricted their water intake to a minimum in the weeks before their
death, it could be argued that they were not actually under the action of the
drug. For this reason additional mice not included in the experiment were used
to test the effect under identical conditions, and were killed when the actual
ingestion ofthiourea was known.
In all the 03H mice of the experiment the results of the examination of the
thyroid gland were similar. Thiourea administered in the drinking water did
not produce hyperplasia or hypertrophy of the thyroid. There was clearly
congestion of the organ which might cause a slight increase in size, but the histo-
logical picture remained normal, showing follicles filled with colloid and lined by
cubic epithelium. None of the mice that died during the period of thiourea
ingestion showed changes in the microscopical picture. Among 20 additional
female adult mice killed after drinking solutions of 0-2 to 0 5 per cent for periods
of a week to 2 months, with actual ingestion of about 5 mg. daily of thiourea,
the size of the thyroid clearly increased in only one, in whichalso histologically
the height of the cells and their disposition in solid acini without colloid
corresponded to the typical picture of thyroid hyperplasia such as is found in
R3 mice.
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It is probable then that thiourea failed to produce any changes in the thyroid,
but the possibility that some of the C3H mice reacted with hyperplasia cannot
be excluded with certainty. Dalton, Morris and Dubnik (1945) and Morris et at.
(1946a) found the typical hyperplasia and the expected increase in size in C3H
mice fed thiourea for long periods. In a more recent paper (Dalton, Morris and
Dubnik, 1948) they noted the wide individual variations in thyroid weight of
thiouracil-treated mice. This lack of reaction to thiourea distinguished the
C3H mice used in these experiments from the Andervont line used by Dalton
et al. Strain differences in the thyroid reaction to thiouracil have been reported
by Dickie and Wooley (1948).
Effects on oestrous cycles and mammary gland.
The effects of thiourea on the oestrous cycles differed sharply in the two
strains used in these experiments. In the R3 mice both of the high and the low
mammary cancer lines, the oestrous cycles remained unaffected even with the
strong concentrations of thiourea which could be administered. Sometimes
slight lengthening of the dioestrous intervals was observed during ingestion of
0*5 per cent and 1 per cent solutions. Most animals had normal oestrous cycles
for the whole ofthe experiment.
C3H mice became anoestrous very soon afterbeginning thiourea administration
and remained so during the whole time of ingestion. Smears taken at intervals
during two week periods in each box were always negative. Morris et al. (1946a)
found regular oestrus only in 3 mice among 21 fed thiourea. Krohn (1947),
using stock albino mice injected daily with propyl-thiouracil, also found irregu-
larities and complete disappearance of cycles. Gorbman (1947) observed an
inhibitory action ofthiourea on the gonads in mice. Arvy and Gabe (1946) and
Pawick (1947) reported inhibition of the oestrus by thiourea and thiouracil in
albino mice without any simultaneous hyperplastic action upon the thyroid
after months of treatment.
Vaginal smears were also taken after discontinuing thiourea ingestion.
Within a period of two weeks to a month the cycles were restored to normal.
This was also the experience of Krohn (1947).
The mammary glands ofthe animals that died during the period oftreatment
showed changes correlated with the state of ovarian function. In R3 mice no
difference from the controls was observed. In C3H mice absence of oestrogenic
activity produced progressive atrophy with few ducts and stunted branching.
Alveolar nodules were seen occasionally.
Effects on tUmour incidence.
Lymphwoma&.-Under this title are included all the tumours of blood-forming
organs, mainly lymphatic glands, thymus, spleen, etc., including the several
types found in the strains with a high spontaneous incidence of such tumours.
The results of thiourea administration are given in Table I. No differences
from the controls were found in the tumour incidence or in tumour age. The
earlier average age of the experimental group was not significant, and the period
of survival of non-tumour animals was slightly longer than in the controls.
The incidence of other tumours was also the same in both groups, and that of
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mammary carcinoma showed the low figures (4 per cent) characteristic of the
MH line of the R3 strain.
Mammary cancer in R3 breeders.-In the original R3 line with high cancer
incidence the results given in Table II are similar in the thiourea-treated mice
and in the controls. The small difference in favour ofthe thiourea group was not
significant, for the small number of animals and the lower tumour age of this
group was also against any inhibitory effect of thiourea. All the tumours
appeared during the period of treatment when some of the mice had received
thiourea for 10 months without interruption.
Mammary cancer in C3H breeders.-Of 49 mice at the start ofthe experiment,
only 29 (effective number) reached the age at which the earliest tumour appeared.
The other 20 died as a consequence of thiourea ingestion. Eight of the 29
TABLE I.-Lymphoma Incidence in R3 Breeding Female8 (MH subline).
Total Effective Mice with Average Average age of
number. number. tumour. %- tumour age. death in non- Other tumours.
Controls . 51 . 42 . 19 . 46 . 384 days . 431 days . 2 mammary cancers.
(216-701) (229-730) . 2 hepatomas.
Thiourea . 55 . 52 . 22 . 42 . 321 days . 454 days . 2 mammary cancers.
(146-621) . (253-591) . 1 hepatoma.
TABLE II.-Mammary Tumour Incidence in C3H and R3 Breeding Females.
Total Effective Mice Average Death age Thyroid Period of
number.number itumur non-tumour hy aoesrus number. nnber. twith %. tumour age. animals. plasa anoestrus.
C3H controls . 53 . 50 . 27 . 54 . 377 days . 421 days . - . -
(222-562) . (242-580)
C3H thiourea-treated 49 . 29 . 8 . 28 457 days . 514 days . . +
(367-538) . (383-677)
R3 controls . 7. 7. 7 .100. 435 days
(301-592)
R3 thiourea-treated 11 . 10 . 7 . 70 . 348 days . 360 days . +
(135-442) . (267-544)
developed mammary cancer. No tumour appeared during the period of treat-
ment. The earliest developed in a mouse 367 days old, 80 days after the with-
drawal of thiourea. This was only 10 days less than the average tumour age
for the control group, which was 377 days. These figures confirmed the assump-
tion that ovarian function and mammary development were normal in the
experimental animals at the average tumour age of the normal mice.
In spite of these normal conditions the percentage of mammary cancer in
the thiourea-treated mice was 28 per cent compared with 54 per cent for the
controls. The difference is statistically significant (X2 3.96). I am indebted
to my colleague, Lr. Spicer, for the statistical analysis of this and the other
results of the experiment. The average tumour age was increased in the experi-
mental animals, and so too was the average life-span of the mice which did not
develop tumours compared with those in the control group. In Table II are
included the relevant figures of the breeders in the high mammary cancer lines,
together with some details of the effects of thiourea on thyroid hyperplasia and
oestrous cycles.E. VAZQUEZ-LOPEZ
Mammary cancer in C3H virgins.-Twenty-one animals died during the period
of thiourea ingestion, and 64 mice survived the 6 months of treatment and
reached the period of appearance of the first tumour. Five among the 64
developed marmmary cancer (8 per cent), at the average age of 571 days. In the
control group 40 out of 96 animals (43 per cent) developed tumours at the average
age of432 days. The earliest tumourin the controls appearedin a mouse 254 days
old. The animals treated were 270 days old when thiourea was withdrawn, so
that ovarian activity and mammary gland development were presumably normal
not only long before the average tumour age ofthe controls, but also very nearly
when the first tumour appeared among the normal mice. Assuming that after
the end of thiourea administration the mice needed a month for total recovery,
theywould be comparable with the normals when 300 days old. Only 4 mammary
cancers developed in the control group below this age.
The decrease in cancer incidence in the thiourea-treated virgins was highly
significant (X2 = 20 9), and confirms the results in C3H breeders. In this group
the average tumour age was also later than in the controls. The average life
span of mice without tumours was longer, but with smaller differences from the
control mice than in the breeders.
Microscopical Study ofOrgans in Thiourea-Treated C3H Mice.
A detailed study of the organs of C3H mice after longer periods of thiouracil
and thiourea ingestion was published by Dalton et al. (1948). The animals were
killed or died during treatment, and although the incidence of miammary cancer
was reduced from 94 per cent to 17 per cent (Morris et al., 1946b), the changes
observed due to the continuous action ofthe drug may have nmasked those directly
related to the inhibition of tumour development.
Huseby, Ball and Visscher (1945) also described alterations found in C3H
mice fed restricted diets which completelyinhibited mammary cancer, and Huseby
and Ball (1945) those in A mice similarly treated. In both cases the restricted
diets were maintained throughout the life of the animals and were effective at
the time ofexamination. In the present experiments the withdrawal ofthiourea
after a limited period ofadministration allowed restoration ofhormonal function,
but the inhibition of tumours persisted. The changes observed in these circum-
stances should be more specifically related to the processes of cancer formation.
TABLE III.-Mammary Cancer Incidence in C3H Virgisn.
Total Effective Mice with Average Average death
number. number. cancer. tumour age. age in tumour Other tumours. mamancrys0.tmuae mice.
Controls . . 96 . 94 . 40 . 43 432 days . 553 days 4 lymphoma.
(254-670) (364-716) . 1 lung cancer.*
Thiourea treated 85 . 64 . 5 . 8 . 571 days . 568 days . 4 lymphomas.
(410-673) . (424-757) . 1 epithelioma.
* Animal with mammary cancer also.
EXPLANATION OF PLATE.
FIG. 1.-Mammary gland of thiourea-treated mouse. C3H virgin, 551 days old. (x 6.)
FIG. 2.-Mammary gland of control mouse of the same age. C3H virgin, 539 days old. ( x 6.)
FIG. 3.-Mammary gland of thiourea-treated mouse showing great dilatation of ducts and
terminal bulbs. C3H virgin, 749 days old. (x 6.)
FIG. 4.-Mammary gland of control mouse of the same age. C3H virgin, 716 days old. (X 6.)
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Two groups of C3H virgins of similar ages were compared. Forty control
mice between 459 and 716 days old (average 574 days) and 50 thiourea-treated,
from 467 to 757 days old (average 574 days), were available for microscopical
study. All were tumour-free. Tumour-bearing mice with and without thiourea
treatment were compared separately, since histological changes in these mice
might be secondary effects of the tumours. Ovaries, uterus, adrenal gland,
thyroid and the complete set of mammary glands in each animal were studied.
Mammary glands.
In mice studied from 150 days onwards after the end of thiourea adminis-
tration the mammary glands were identical to the glands of control mice of the
same age in general structure, pattern, branching and extension. In both groups
there was aprogressive butverygradualdecrease in size andrichness ofbranching,
and in most cases the development ofthe glands was correlated with the general
condition and weight ofthe mouse rather than with its age. Fig. 1 and 2 show
glands of control and experimental mice ofapproximately the same age.
The two main differences between thiourea-treated and control mice are the
number of nodules of alveolar hyperplasia and the width of the ducts. The
alveolar nodules of one gland or even of all the glands in a single mouse cannot
be used to distinguish a thiourea-treated from a control mouse; in some thiourea-
treated animals the number and distribution of nodules is the same as in the
controls. The group as a whole, however, shows significant differences, both in.
the number and in the distribution ofnodules. The counts of the total number
ofnodules in tumour-free mice with and without thiourea are given in Table IV.
TABLE IV.-Alveolar Nodules in C3H Mice (Virgin).
Number Average
Number Aver a of mice / Total of nmimber
ofmice. erage ge. with 0 nodules. ofnodules
nodules. per mouse.
Controls . . 40 . 574 days . 30 . 75 . 526 . 17-3
(456-716)
Thiourea-treated 50 . 574 days . 39 . 78 . 310 . 7.3
(447-757)
A small proportion of animals, about the same in both groups, had none. In
those mice the glands were poorly developed and almost atrophic, and although
the atrophy of the mamma should not prevent the persistence of the alveolar
hyperplasia, it is most probable that the absence of nodules reflects the general
condition of the animals rather than any specific cause. The thiourea-treated
mice, as a whole, had considerably fewer nodules ofalveolar hyperplasia than the
control mice, and the average number of nodules per mouse was less than half
the figure for the controls.
There are no records of comparative counts in similar experiments with
reduced mammary cancer incidence, but Huseby and Bittner (1946) report that
less than 1 nodule per 4 glands was found in some animals more than 340 days
old kept on the restricted diet in the experiments of Huseby et al. (1945).
The distribution of the nodules per gland given in Table V shows additional
points ofinterest. The smaller number in the thiourea-treated mice was not due
27
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to indiscriminate reduction affecting equally all the glands ofeach animal, but to
a clear decrease of the number of glands with'nodules. Only 32 per cent of the
glands in the thiourea-treated mice had nodules compared with 51 per cent in
the control group. There were also significant differences in the distribution
and the average number ofnodules for glands in each group, but the main effect
of the thiourea administration is to increase the number of glands without any
nodules. As the hormonal and systemic influences are the same for all the
mammary glands in each mouse the cause of these differences between glands in
the same mouse must be the result of local factors whose activity is restricted
to the fields represented by particular glands. Thiourea acts systemically mainly
by stopping ovarian function and oestrogen production. The effect of this lack
of oestrogen, manifested in the different numbers of alveolar nodules, seems to
depend on local factors independent ofthe general morphogenetic action.
TABLE V.-Alevolar Nodules: Distribution per Gland.
Number of Total Average
Number glands % number of number of
ofglands. with nodules. oue nodules. nodules. per gland.
Controls . . 370 . 190 . 51 . 526 . 27
Thiourea-treated . 474 . 150 . 32 . 310 . 2
TABLE VI.-Alveolar Nodules in C3H Mice (Virgins) with Tumounr.
Number Total Average
Number of mice
t number of number of
ofmice. withn nodules. nodules nodules. ~~~~~per mouse.
Controls . . 18 . 18 . 100 . 462 . 25-7
Thiourea-treated . 5 . 5 . 100 . 73 . 142
TABLE VII.-Alveolar Nodules: Distribution per Gland.
Number Total Average
Number of glands n °b f number
ofglands with nl number o ofnodules
noue, nodules. per gland.
Controls . . 145 . 122 . 84 . 462 . 3.7
Thiourea-treated . 43 . 36 . 83 . 73 . 2-0
The number of alveolar nodules in glands of control and thiourea-treated
mice with tumours was also counted and the results are given in Table VI. There
is a notable increase in the number compared with the tumour-free animals, but
the difference between control and experimental groups persists. The distri-
bution per gland is given in Table VII. The small number ofanimals makes the
values of doubtful significance. The average number per gland in the thiourea-
treated mice remains the same as in tumour-free animals. The percentage of
glands with nodules is equal in both groups of mice without difference between
thiourea-treated and controls.
The other difference between the mammary glands of the control and experi-
mental mice affected the glandular ducts. It was not visible in all the animals,
but usually, when it existed, affected all the ducts and glands of the animal to
the same degree. It appeared in mice under 400 days old, and increased in fre-
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reached three or four times the width of the normal. It is mostly visible in the
main duct, but affected the whole extension ofthe gland, including the end bulbs
and lateral buds, which appeared almostspherical. At the post-mortem examina-
tion the ducts appeared full of whitish material, which made them conspicuous
to the naked eye. It seemed therefore to be due to engorgement by a secretory
product, but it could exist in glands without any indication of alveolar prolifera-
tion. Fig. 3 shows glands of treated mice with wide dilated ducts, and Fig. 4
glands ofcontrol mice ofthe same age.
Dilatation of ducts has been described in oestrogen-treated animals of both
sexes (Burrows, 1936; Gardner, 1941) and by Bonser (1936) without association
with proliferating acini. In cross-suckling experiments, wide dilated ducts with
blunt or rounded tips, similar to those found in thiourea-treated mice, have been
found in oestradiol-treated Strong A males and 057 normal females, nursed by
C3H mothers (Khanolkar and Ranadive, 1947).
Other organs.
It has been already mentioned that the thyroid gland of the experimental
mice did not show any alteration inhistological structure in mice whichpreviously
had suffered hyperplasia during thiourea administration. The ovaries and uterus
of control and treated mice did not differ in any particular. Some ovaries
appeared in regressed condition without corpora lutea or follicular development;
this occurred with the same frequency in both groups. Most ovaries had follicles
in all stages of development, and some of the corpora lutea became hyalinized,
forming large homogeneous masses with few cells. This formation of corpora
albicantis is probably a strain characteristic, since Fekete (1946) found them in
the dba high cancer strain, but never in the C57 black strain. Huseby et al.
(1945) found them only in one C311 mouse with mammary-cancer, and in none of
the diet restricted animals oftheir experiment. That is probably another ofthe
characteristics in which the C3H mice used here differ from those in American
laboratories. The corpora albicantis were very prominent among the cancer-
bearing animals, and their ovaries owed their large size partly to these structures.
Apart from their size, however, the ovaries of mice with tumours showed mature
follicles and abundant corpora lutea, which suggested normal activity. These
findings were contrary to the results of Allen, Diddle, Strong, Burford and
Gardner (1935) in several strains of mice, including the C31.
In all groups the condition of the uterus reflects that of the ovaries having
tall epithelium, extensive glandular development and loose cellular stroma in
the animals with well functioning ovaries and signs of regression in those with
ovarian atrophy.
No differences were found in the adrenal glands of thiourea-treated mice
compared with the controls. The most important change, affecting both groups
equally, was the presence ofamyloid degeneration, which appeared on the border-
line between cortex and medulla and progressed towards the glomerular zone
with advancing age. In the oldest animals amyloid invaded most of the cortex,
and only two or three layers of cortical cells remained intact. The medulla was
never affected. " Brown degeneration " was, on the contrary, never found in
C311 mice, but was almost constant in R3 animals of high or low mammary
cancer lines. Amyloid degeneration ofthe same type was described by Blaisdell,
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Gardner and Strong (1941) in C3H mice and in other strains with and without
cancer susceptibility. Dunn (1944) found it also in 03H mice and their hybrids.
The incidence and extension of adrenal amyloidosis was independent of
thiourea treatment, but a difference was found between the tumour and non-
tumour-bearing animals of each group, at the same age. Table VIII gives the
results in non-tumour animals, 92 per cent of which showed variable degrees of
amyloid invasion. Table IX shows the frequency of amyloid in animals with.
mammary cancer and some other spontaneous tumours. The mammary cancer
group includes control and thiourea-treated mice. The percentage of tumour-
bearing animals with amyloid was 41 per cent, and the difference from tumour-free
mice of similar age is statistically significant (X2 = 17.4). It cannot be decided
if this resistance to adrenal degeneration is directly related to the tumour
development. The fact that tumour-bearing animals maintain better ovarian
structure than non-tumour animals of the same age seems to favour instead a
correlation between ovarian activity and adreno-cortical condition.
TABLE VIII.-Amyloid Degeneration ofAdrenals in C3H Virgine without Tumours.
Number ~~~~Number Number Age. with of mice. ~~~~~amyloid.
Controls . . . 27 . 471-716 days . 25
Thiourea-treated . . 25 . 525-749 ,, . 23
Total . . 52 . .. . 48 . 92
TABLE IX.-Amyloid Degeneration of Adrenals in C3H Virgins with Tumours.
Number Ag.Number oNfmnibce.
Age.
amyloid.
Mammary cancers . 16 . 423-715 days . 8
Lymphoma . . . 5 . 502-692 ,, . 2
Epithelioma . . 1 . 590 days .
Total . . . 22 . .. . 10 . 41
DISCUSSION.
From the observations described it may be concluded that the main effect
of thiourea in C3H mice is the maintenance of anoestrus during the period of
administration. The possibility of a temporary hypothyroidism cannot be
excluded, but the significance of thyroid function for tumour production is very
much reduced when it is considered that in R3 mice the incidences ofmammary
cancer and lymphoma are completely unaffected, in spite ofconsiderable enlarge-
ment of the gland. Ifhypertrophy is accompanied by changes in the metabolic
rate comparable to those taking place in rats or man, the influence of caloric
intake per se is not very important in the genesis of malignant tumours. The
possibility of a specific activity of thiourea on blood-forming tissues and their
neoplasms suggested by the agranulocytic reactions in patients treated with
goitrogenic substances is not supported by the results in the MH high lymphoma
line which agree with clinical reports of treatment of leukaemic patients
(Limarzi, Kulasavage and Pirani, 1946; Hansen-Pruss, 1947).
That lack of oestrogen is the effective factor is shown also by the normal
incidence of cancer corresponding with regular oestrus in spite of thiourea
administration in R3 mice. The correlation between ovarian inhibition andEFFECTS OF THIOUREA ON SPONTANEOUS TUMOURS
decrease in mammary cancer proved by Lathrop and Loeb in 1916 is one of the
oldest and probably the most often quoted experiment in hormonal cancer
research. The results of ovariectomy are confirmed by the effects-of hormones
which antagonize oestrogenic activity such as that of testosterone (Lacassagne,
1939; Nathanson and Andervont, 1939; Lacassagne and Reynaud, 1939;
Jones, 1941; Heiman, 1944). The action of progesterone is still a matter for
discussion (Lacassagne, 1937; Heiman, 1945; Burrows and Hoch-Ligeti, 1946).
Indirect ways of decreasing oestrogenic activity give, however, less clear results.
Although low cystine diets completely inhibit mammary cancer in C3H mice
(White and Andervont, 1943), the effects ofstilboestrol pellets which restore the
development of the mammary glands raise the incidence only to 44 per cent
compared with 92 per cent in the controls (White and White, 1944). In similar
experiments, Ball, Huseby and Visscher (1946) found that in spite of continuous
administration of stilboestrol the mammary glands of Strain A mice maintained
on restricted diets during 15 months were considerably less developed than those
of control mice. The possibility ofother hormonal factors influencing mammary
cancer development is also suggested by the results of Shimkin and Wyman
(1945), who found greater reduction in adrenalectomized C3H mice than after
ovariectomy, and by the observation of Wallace, Wallace and Mills (1945) of
persistence of effects of temperature in mammary cancer incidence after ovariec-
tomy.
The results of temporary lack of oestrogenic activity caused by thiourea
show that reduction ofmammary cancer is not due to defective glandular develop-
ment, and therefore that the hormonal effects are not limited7 to the morpho-
genesis of tissue susceptible to carcinogenic agents. Mammary glands of two
groups of mice of the same strain with different cancer incidences have identical
morphology, and only differ in the total number ofnodules ofalveolarhyperplasia
in each group. The significance of these nodules of alveolar hyperplasia in
relation to carcinogenesis has been indicated by several authors. The same
factors involved in the genesis of mammary cancer are necessary for the alveolar
hyperplasia. Huseby and Bittner (1946) have shown by the study of C3H and
hybrid mice with or without the " milk influence " that this influence is necessary
for the presence of nodules. The importance of the " inherited hormonal
influence " is shown by the absence of nodules in virgins of the A strain. The
significance of each factor for the development and persistence of the alveolar
hyperplasia has been studied by Pullinger (1947), who provoked early appearance
ofnodules in males and ovariectomized virgins ofR3 and C3H strains by injection
of measured doses of oestrogens. Although alveolar hyperplasia is induced by
oestrogens in mice without the milk influence, the persistence and autonomy of
the alveolar hyperplasia requires the presence of the Bittner factor, and they
disappear gradually in mice deprived of it. There is no nodular formation in
A virgins injected with the amounts of oestrogens that are effective in other
strains.
These are sufficient reasons for considering the alveolar hyperplasia as the
result of the sum of hormonal and milk-transmitted influences, affecting the
mammary glands of strains genetically susceptible to spontaneous tumour
formation. The* number of glands with nodules is considerably smaller in
thiourea-treated mice. The hormonal influences in the thiourea treated mice
seem to have been sufficient to reach the level necessary for the development of
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nodules in the sameproportion ofmice as in the controls, in spite ofthe temporary
inhibition of oestrus. The distension of ducts found also in the thiourea-
treated group seems to be a sign of excessive oestrogenic stimulation, and may
indicate compensatory excess after thiourea withdrawal.
If the hormonal influences are sufficient for the alveolar development the
smaller number of glands with nodules, which is the main result of thiourea
administration, must be due to local factors. The lack of oestrogens (and its
possible compensation afterwards) affects all the glands of the mice equally.
These results point to the possibility of effects on local factors and producing
different consequences in each gland of the same animal. The local factor
involved in the persistence of alveolar nodules is the milk factor, and the distri-
bution of nodules suggests that it is affected by thiourea administration.
There are no grounds for supposing that thiourea can directly influence the
milk factor, but there are some in favour of an indirect action resulting from the
lack of oestrogens. Apart from the considerable number of experiments on the
effects of oestrogen adninistration on cancer incidence, there is evidence even in
normal circumstances of hormonal influences in breeding and forced breeding,
increasing the number of tumours. The number of litters also increases the
incidence in breeders (Jones, 1940; Andervont, 1941). The higher incideixce in
mice born in later litters compared with the earliest from the same mother has
been explained by the different concentration ofthe milk influence with advancing
age (Bittner, 1942a). If the increased hormonal stimulation is the cause of
increase in the amount or activity of the milk influence, it is probable that the
converse holds true also, and that the lack ofhormones acts in theoppositesense.
The relative importance of the hormonal influence among the three factors
necessary for the genesis of spontaneous mammary cancer in mice is not exactly
known. Opinions range *from that of Shimkin and Andervont (1941), who
consider the hormonal factors as necessary only for the creation of a substratum
for the carcinogenic action of the factor transmitted by the milk, to that of
Warner, Reinhard and Goltz (1945), who maintain the dominance in certain
cases of the inherited susceptibility upon the concentration of the milk agent.
Loeb, Suntzeff, Burns and Schenken (1944) believe that the oestrogens act by
stimulating the growth of the mammary tissue and sensitizing it to all types of
stimuli, and Bonser (1945) as a developing factor acting upon breast tissues
already sensitized by the milk factor. The only common feature of all these
opinions is to consider the different factors as completely independent variables.
On this basis the opinion ofBittner (1942b) that each influence must be considered
as complementary to the others and all equally important is, besides being non-
controversial, nearest to the observed facts. But ifthere are some factors which
are affected and increased, or even created de novo by interaction of the others,
the relative significance of each would not be the same.
The effect ofgenetic susceptibility on some aspects ofthe milk factor activities
has been already proved by Heston, Deringer and Andervont (1945). The
effect ofthe inherited hormonal influence as suggested by the result ofthe inhibi-
tion of oestrogenic activity would be another example of similar interaction.
SUMMARY.
1. The effects of thiourea in mice depend on strain characteristics. R3 mice,
whether of high or low mammary cancer sublines, react with great thyroid
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hyperplasia and without disturbance of the oestrous cycles. The incidence of
lymphomas in the MH line of R3 or of mammary cancer in the original R3
strain is not affected by thiourea administration.
-2. In C3H mice thiourea does not produce any thyroid reaction, but the
animals remain anoestrous during the period of administration. The incidence
of mammary cancer in virgins and breeding females of the C3H strain is con-
siderably reduced by administration of thiourea during a period of six months,
ending before the average tumour age ofthe control mice.
3. Microscopical study of the organs of tumour-free C3H mice treated with
thiourea shows divergences from the control group only in the number ofnodules
ofalveolar hyperplasia and in the width ofthe ducts ofthe mammary glands.
4. The distribution ofthe alveolar nodules suggests that ingestion ofthiourea
affects local factors involved in the development of alveolar hyperplasias.
5. Inasmuch as the effects of thiourea in C3H mice are due to the lack of
oestrogenic function during the period ofingestion, the effect ofhormonal factors
on the genesis of mammary cancer is not limited to the development of the
mammary gland, but affects also the local factors involved in the development
ofalveolar hyperplasia.
6. The significance of these findings is discussed, and it is concluded that the
milk influence is the local factor involved in the development of mammary
cancer and alveolar hyperplasia, that it is affected by the lack of oestrogens, and
therefore that the " milk influence " is affected by the "inherited hormonal
influence."
REFERENCES.
ALLEN, E., DIDDLE, A. W., STRONG, I. C., BURFORD, T. H., AND GARDNER, W. U.-
(1935) Amer. J. Cancer, 25, 291.
ANDERVONT, H. B.-(1941) J. nat. Cancer Inst., 2, 307.
ARVY, L., AND GABE, M.-(1946) C.R. Soc. biol., Paris, 140,945.
BALL, Z. B., HUSEBY, R. A., AND VISSCHER, M. B.-(1946) Cancer Res., 6, 493.
BITTNER, J. J.-(1942a) Ibid., 2, 540.-(1942b) Ibid., 2, 710.
BLAISDELL, J. S., GARDNER, W. U., AND STRONG, L.-(1941) Ibid., 1, 283.
BONSER, G. M.-(1936) J. Path. Bact., 42, 169.-(1945) Ibid., 57, 413.
BURROWS, H.- (1936) Ibid., 42,161.
Idem AND HOCH-LIGETI, C.-(1946) Cancer Res., 6, 608.
DALTON, A. J., MORRIS, H. P., AND DUBNIK, C. S.-(1945) J. nat. Cancer Inst., 5, 451.-
(1948) Ibid., 9, 201.
DICKIE, M. M., AND WOOLEY, G. W.-(1948) Crenetics, 33, 102.
DUNN, J. B.-(1944) J. nat. Cancer Inst., 5, 17.
FERETE, E.-(1946) Cancer Res., 6, 263.
GARDNER, W. U.-(1941) Ibid., 1, 345.
GORBMAN, A.-(1947) Ibid., 7, 746.
HANSEN-PRUSS, 0. C.-(1947) Proc. Soc. exp. Biol., N.Y.; 64, 486.
HEIMAN, J.-(1944) Cancer Res., 4, 31.-(1945) Ibid., 5, 426.
HESTON, W. E., DERINGER, M. K., AND ANDERVONT, H. B.-(1945) J. nat. Cancer
Inst., 5, 289.
HUSEBY, R. A., AND BALL, Z. B.-(1945) Anat. Rec., 92, 135.
Iidem AND VISSCHER, M. B.-(1945) Cancer Res., 5, 40.
Idem., AND BITTNER, J. J.-(1946) Ibid., 6, 240.
JONES, E. E.-(1940) Amer. J. Cancer, 39, 94.-(1941) Cancer Res., 1, 787.414 L. A. ELSON AND L. F. LAMERTON
KHANOLKAR, V. R., AND RANADIVE, K. J.-(1947) J. Path. Bact., 59, 593.
KROHN, P. L.-(1947) J. Endocrinol., 5, 33.
LACASSAGNE, A.-(1937) C.R. Soc. Biol. Paris, 126, 385.-(1939) Bull. Ass. fran9.
Cancer, 28, 951.
Idem AND REYNAUD, M.- (1939) C.R. Soc. Biol. Paris, 132, 431.
LATHROP, A. E. C., AND LOEB, L.-(1916) J. Cancer Res., 1, 1.
LIMARZI, I. R., KULASAVAGE, R. J., AND PIRANI, C. L.-(1946) Blood, 1, 426.
LOEB, L., SUNTZEFF, V., BURNS, I. L., AND SCHENKEN, L. R.-(1944) Arch.
Path., 38, 52.
MORRIS, H. P., DUBNIK, C. S., AND DALTON, A. J.-(1946a) J. nat. Cancer Inst., 7, 159.-
(1946b) Cancer Res., 6, 482.
NATHANSON, I. J., AND ANDERVONT, H. B.-(1939) Proc. Soc. exp. Biol., N.Y., 40, 421.
PAWIK, W.-(1947) C.R. Soc. Biol. Paris, 141, 1108.
PULLINGER, B. D.-(1947) Brit. J. Cancer, 1, 177.
SHIMKIN, M. B., AND ANDERVONT, H. B.-(1941) J. nat. Cancer Inst., 1, 599.
Idem AND WYMAN, R. S.-(1945) Ibid., 6, 187.
VAZQUEZ-LOPEZ, E.-(1946) 43rd Ann. Rep. imp. Cancer Res. Fd., p. 10.
WALLACE, E. W., WALLACE, H., AND MILLS, C. A.-(1945) Cancer Res., 5, 47.
WARNER, S. G., REINHARD, M. C., AND GOLTZ, H. L.-(1945) Ibid., 5, 584.
WHITE, J., AND ANDERVONT, H. B.-(1943) J. nat. Cancer Inst., 3, 449.
WHITE, F. R., AND WHITE, J.-(1944) Ibid., 4, 413.
THE INFLUENCE OF THE PROTEIN CONTENT OF THE DIET
ON THE RESPONSE OF WALKER RAT CARCINOMA 256
TO X-RADIATION.
L. A. ELSON AND L. -F. LAMERTON.
From the Chester Beatty Research Institute, and the Physics Department,
The Royal CancerHospital, London, S.W.3.
Received for publication July 16, 1949.
IN an investigation of the body growth- and tumour growth-inhibiting action
of carcinogenic substances, it was found that the nature of the inhibition is
profoundly influenced by the protein content of the diet (Elson and Warren,
1947; Elson and Haddow, 1947; Elson, 1949). In rats maintained on a 20
per cent protein diet injection of the carcinogen usually has little immediate
effect on body growth although a delayed action, resulting in rapid loss ofweight
followed by death, may occur later. On the other hand, animals maintained on a
10 per cent protein diet respond to the injection by an immediate retardation
of growth.
Treatment with the .carcinogenic hydrocarbon 1:2:5:6-dibenzanthracene
24 hours after implantation of Walker carcinoma 256 in rats maintained on a
20 per cent protein diet results in very little difference in size and weight of
the tumours from those ofcontrols. If, however, the animals are fed a 5 per cent
protein diet the tumours of those similarly treated with dibenzanthracene were
found to be only one-quarter the weight of those of controls when the rats were
killed 13 days after implantation (Elson and Haddow, 1947). A much greater
inhibition oftumour growth has been obtained with derivatives of4-aminostilbene